EGRX News and Press, Eagle Pharmaceuticals Inc. From 11/30/23

The law firm of Kirby McInerney LLP is investigating potential claims against Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX ). The investigation concerns whether Eagle and/or certain of its officers have violated the federal securities la...

Boston, Massachusetts--(Newsfile Corp. - November 29, 2023) - Block & Leviton is investigating Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) for potential securities law violations. Investors who have lost money in their Eagle Pharmaceuticals, Inc. investment should contact the firm  to le...

2023-11-29 13:02:14 ET More on mid-day movers stocks. Sonder Holdings Inc. (SOND) Q3 2023 Earnings Call Transcript Fusion Fuel receives purchase order from Portuguese energy company for 1.25 MW electrolyzer facility Fusion Fuel Green receives Nasdaq notice regarding ...

2023-11-29 08:35:49 ET More on Eagle Pharmaceuticals Seeking Alpha’s Quant Rating on Eagle Pharmaceuticals Historical earnings data for Eagle Pharmaceuticals Financial information for Eagle Pharmaceuticals For further details see: Eagle Pharmaceuti...

2023-11-29 07:47:52 ET More on Eagle Pharmaceuticals Seeking Alpha’s Quant Rating on Eagle Pharmaceuticals Historical earnings data for Eagle Pharmaceuticals Financial information for Eagle Pharmaceuticals For further details see: Eagle Pharmaceuti...

WOODCLIFF LAKE, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on November 27, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&...

– CEO and Founder Scott Tarriff Retires – – Chairman Michael Graves to Serve as Interim Executive Chairman – WOODCLIFF LAKE, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company&#...

WOODCLIFF LAKE, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it will be delaying the release of its third quarter 2023 results and investor conference call, previously scheduled for t...

WOODCLIFF LAKE, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its third quarter 2023 financial results on Thursday, November 9, 2023, before the market opens. ...

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...